These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7848334)

  • 1. Effect of nisoldipine on red cell deformability and platelet aggregation in stroke patients.
    Kuzuya F; Hayakawa M
    Arzneimittelforschung; 1994 Nov; 44(11):1214-6. PubMed ID: 7848334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vinpocetine on red blood cell deformability in stroke patients.
    Hayakawa M
    Arzneimittelforschung; 1992 Apr; 42(4):425-7. PubMed ID: 1642666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nicergoline on platelet aggregation, plasma viscosity and erythrocyte deformability in geriatric patients with cerebral infarction. Preliminary report.
    Nagakawa Y; Akedo Y; Kaku S; Orimo H
    Arzneimittelforschung; 1990 Aug; 40(8):862-4. PubMed ID: 2122905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nitric oxide and prostacyclin on deformability and aggregability of red blood cells of rats ex vivo and in vitro.
    Starzyk D; Korbut R; Gryglewski RJ
    J Physiol Pharmacol; 1999 Dec; 50(4):629-37. PubMed ID: 10639013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests.
    Koltai K; Feher G; Kesmarky G; Keszthelyi Z; Czopf L; Toth K
    Clin Hemorheol Microcirc; 2006; 35(4):517-25. PubMed ID: 17148851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of aspirin on rheological properties of erythrocytes in essential hypertension].
    Korbut RA; Adamek-Guzik T
    Przegl Lek; 2002; 59(2):71-5. PubMed ID: 12152252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of blood hematocrit and erythrocyte deformability on adenosine 5'-diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy.
    Cecchi E; Marcucci R; Paniccia R; Bandinelli B; Valente S; Giglioli C; Lazzeri C; Gensini GF; Abbate R; Mannini L
    Am J Cardiol; 2009 Sep; 104(6):764-8. PubMed ID: 19733708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin.
    Bozzo J; Hernández MR; Ordinas A
    Cardiovasc Res; 1995 Nov; 30(5):725-30. PubMed ID: 8595619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vinpocetine on platelet aggregability and erythrocyte deformability.
    Kuzuya F
    Ther Hung; 1985; 33(1):22-34. PubMed ID: 3841997
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of felodipine-ER on blood pressure, platelet function, and rheological properties in hypertension.
    Chou TZ; Lee KW; Ding YA
    Can J Cardiol; 1993 Jun; 9(5):423-7. PubMed ID: 8394193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ADP-induced platelet aggregation in vascular diseases of the elderly].
    Pernigotti L; Molaschi M; Macchione C; Ferrario E; Poli L
    Minerva Med; 1981 Oct; 72(39):2617-20. PubMed ID: 7290465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nisoldipine in primary Raynaud's phenomenon.
    Challenor VF; Waller DG; Francis DA; Francis JL; Mani R; Roath S
    Eur J Clin Pharmacol; 1987; 33(1):27-30. PubMed ID: 3691593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorrheologic effects of pyrimido-pyrimidine derivatives.
    Ambrus JL; Stadler I; Kulaylat M; Koreshi A; Akhtar S
    J Med; 1996; 27(1-2):21-32. PubMed ID: 8863175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacodynamic approach to the optimal use of calcium antagonists in patients with cerebrovascular disorders].
    Akopov SE; Grigorian GS; Tunian IuS; Gabrielian ES
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(1):67-71. PubMed ID: 1647113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amlodipine on platelet aggregation and blood pressure in patients with essential hypertension.
    Hernández R; Carvajal AR; Armas-de Hernandez MJ; Guerrero-Pajuelo J; Armas-Padilla MC; Barragan O; Machado-de Alvarado I
    Clin Ther; 1993; 15(2):304-13. PubMed ID: 8519039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of nisoldipine in essential hypertension.
    Blau A; Herzog D; Herz I; Battler A; Schechter P; Eliahou HE
    Isr J Med Sci; 1994 Feb; 30(2):139-45. PubMed ID: 8150600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemorheological disturbances in patients with chronic cerebrovascular diseases.
    Szapary L; Horvath B; Marton Z; Alexy T; Demeter N; Szots M; Klabuzai A; Kesmarky G; Juricskay I; Gaal V; Czopf J; Toth K
    Clin Hemorheol Microcirc; 2004; 31(1):1-9. PubMed ID: 15272148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.